24 HR ropinirole 4 MG Extended Release Oral Tablet Requip
1 INDICATIONS AND USAGE REQUIP XL is indicated for the treatment of Parkinson’s disease. REQUIP XL is a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease. ( 1 )
GlaxoSmithKline LLC
OVAL BROWN GS WXG
GS WXG OVAL BROWN
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Each biconvex, capsule-shaped, film-coated tablet contains ropinirole hydrochloride equivalent to the labeled amount of ropinirole as follows: • 2 mg: pink tablets debossed with “GS” and “3V2” in bottles of 30 (NDC 0007-4885-13). • 4 mg: light brown tablets debossed with “GS” and “WXG” in bottles of 30 (NDC 0007-4887-13). • 6 mg: white tablets debossed with “GS” and “11F” in bottles of 30 (NDC 0007-4883-13). • 8 mg: red tablets debossed with “GS” and “5CC” in bottles of 30 (NDC 0007-4888-13). • 12 mg: green tablets debossed with “GS” and “YX7” in bottles of 30 (NDC 0007-4882-13). Storage Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP.
More pills like OVAL GS WXG